Guerbet SA (GBT.PA)
EUR 19.26
(-1.03%)
EUR 19.26
(-1.03%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 646.97 Million EUR | 15.52% |
| 2022 | 560.07 Million EUR | -5.99% |
| 2021 | 595.74 Million EUR | 3.08% |
| 2020 | 577.95 Million EUR | -6.73% |
| 2019 | 619.67 Million EUR | -13.22% |
| 2018 | 714.04 Million EUR | 16.78% |
| 2017 | 611.45 Million EUR | -14.28% |
| 2016 | 713.35 Million EUR | 15.05% |
| 2015 | 620.05 Million EUR | 186.36% |
| 2014 | 216.53 Million EUR | -2.15% |
| 2013 | 221.29 Million EUR | -5.73% |
| 2012 | 234.75 Million EUR | -0.07% |
| 2011 | 234.92 Million EUR | 11.08% |
| 2010 | 211.49 Million EUR | 11.89% |
| 2009 | 189.01 Million EUR | -4.17% |
| 2008 | 197.23 Million EUR | 5.89% |
| 2007 | 186.25 Million EUR | 6.81% |
| 2006 | 174.37 Million EUR | 12.75% |
| 2005 | 154.65 Million EUR | 14.17% |
| 2004 | 135.46 Million EUR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 654.36 Million EUR | 0.0% |
| 2023 Q4 | 646.97 Million EUR | 0.0% |
| 2023 FY | 646.97 Million EUR | 15.52% |
| 2023 Q2 | 620.96 Million EUR | 0.0% |
| 2022 Q2 | 576.36 Million EUR | 0.0% |
| 2022 Q4 | 560.07 Million EUR | 0.0% |
| 2022 FY | 560.07 Million EUR | -5.99% |
| 2021 FY | 595.74 Million EUR | 3.08% |
| 2021 Q2 | 572.75 Million EUR | 0.0% |
| 2021 Q4 | 595.74 Million EUR | 0.0% |
| 2020 Q4 | 581.4 Million EUR | 0.0% |
| 2020 Q2 | 589.95 Million EUR | 0.0% |
| 2020 FY | 577.95 Million EUR | -6.73% |
| 2019 Q4 | 619.67 Million EUR | 0.0% |
| 2019 FY | 619.67 Million EUR | -13.22% |
| 2019 Q2 | 700.54 Million EUR | 0.0% |
| 2018 Q4 | 714.04 Million EUR | 0.0% |
| 2018 FY | 714.04 Million EUR | 16.78% |
| 2018 Q2 | 687.68 Million EUR | 0.0% |
| 2017 Q2 | 638.01 Million EUR | 0.0% |
| 2017 FY | 611.45 Million EUR | -14.28% |
| 2017 Q4 | 611.45 Million EUR | 0.0% |
| 2016 Q2 | 654.11 Million EUR | 0.0% |
| 2016 FY | 713.35 Million EUR | 15.05% |
| 2016 Q4 | 713.35 Million EUR | 0.0% |
| 2015 FY | 620.05 Million EUR | 186.36% |
| 2015 Q4 | 620.05 Million EUR | 0.0% |
| 2015 Q2 | 219.77 Million EUR | 0.0% |
| 2014 Q2 | 222.04 Million EUR | 0.0% |
| 2014 Q4 | 216.53 Million EUR | 0.0% |
| 2014 FY | 216.53 Million EUR | -2.15% |
| 2013 Q4 | 221.29 Million EUR | 0.0% |
| 2013 Q2 | 238.58 Million EUR | 0.0% |
| 2013 FY | 221.29 Million EUR | -5.73% |
| 2012 Q2 | 239.83 Million EUR | 0.0% |
| 2012 FY | 234.75 Million EUR | -0.07% |
| 2012 Q4 | 234.75 Million EUR | 0.0% |
| 2011 Q4 | 234.92 Million EUR | 0.0% |
| 2011 Q2 | 216.54 Million EUR | 0.0% |
| 2011 FY | 234.92 Million EUR | 11.08% |
| 2010 FY | 211.49 Million EUR | 11.89% |
| 2010 Q2 | 204.88 Million EUR | 0.0% |
| 2010 Q4 | 211.49 Million EUR | 0.0% |
| 2009 FY | 189.01 Million EUR | -4.17% |
| 2009 Q4 | 189.01 Million EUR | 0.0% |
| 2008 FY | 197.23 Million EUR | 5.89% |
| 2007 FY | 186.25 Million EUR | 6.81% |
| 2006 FY | 174.37 Million EUR | 12.75% |
| 2005 FY | 154.65 Million EUR | 14.17% |
| 2004 FY | 135.46 Million EUR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Affluent Medical SA | 25.15 Million EUR | -2472.343% |
| Bluelinea Société Anonyme | 8.86 Million EUR | -7198.272% |
| Carmat SA | 96.83 Million EUR | -568.143% |
| Diagnostic Medical Systems S.A. | 37.41 Million EUR | -1629.127% |
| Euromedis Groupe | 23.66 Million EUR | -2633.635% |
| Eurobio Scientific Société anonyme | 141.15 Million EUR | -358.334% |
| Ikonisys S.A. | 5.11 Million EUR | -12536.256% |
| Implanet S.A. | 10.81 Million EUR | -5884.368% |
| Median Technologies SA | 46.22 Million EUR | -1299.52% |
| SpineGuard SA | 5 Million EUR | -12830.599% |
| Theraclion SA | 13.01 Million EUR | -4870.357% |
| Euroapi S.A. | 684.7 Million EUR | 5.51% |